X-Square Capital’s Braskem BAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.22M Hold
500,900
0.31% 86
2026
Q1
$1.83M Buy
500,900
+315,900
+171% +$1.2M 0.62% 58
2025
Q4
$546K Buy
185,000
+100,000
+118% +$274K 0.18% 117
2025
Q3
$206K Hold
85,000
0.06% 152
2025
Q2
$279K Hold
85,000
0.1% 138
2025
Q1
$327K Hold
85,000
0.14% 130
2024
Q4
$328K Hold
85,000
0.13% 132
2024
Q3
$624K Hold
85,000
0.27% 89
2024
Q2
$548K Hold
85,000
0.25% 97
2024
Q1
$895K Hold
85,000
0.42% 72
2023
Q4
$750K Buy
+85,000
New +$649K 0.41% 78

Other funds holding BAK

X-Square Capital's BAK Position: Q2 2026 in Review

X-Square Capital held its Braskem (BAK) position steady in Q2 2026 at 500,900 shares worth $1.22M. The position accounts for 0.31% of the portfolio, ranked #86.

X-Square Capital first reported a position in BAK in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.83M in Q1 2026. 63 funds tracked by Wall St. Rank hold BAK as of Q2 2026.

  • X-Square Capital held 500,900 shares of Braskem worth $1.22M as of Q2 2026.
  • X-Square Capital left its Braskem share count unchanged in Q2 2026.
  • Braskem made up 0.31% of X-Square Capital's portfolio in Q2 2026, its #86 holding.
  • X-Square Capital first reported a position in Braskem in Q4 2023 and has held it in 11 quarters since.
  • X-Square Capital's Braskem position peaked at $1.83M in Q1 2026.
  • 63 funds tracked by Wall St. Rank held Braskem as of Q2 2026.

Based on X-Square Capital's 13F filing for Q2 2026, filed 12 Aug 2026.